Authors:
Noordam, C
van der Burgt, I
Sengers, RCA
Delemarre-van de Waal, HA
Otten, BJ
Citation: C. Noordam et al., Growth hormone treatment in children with Noonan's syndrome: four year results of a partly controlled trial, ACT PAEDIAT, 90(8), 2001, pp. 889-894
Authors:
Noordam, C
van der Burgt, I
Sweep, CGJ
Delemarre-van de Waal, HA
Sengers, RCA
Otten, BJ
Citation: C. Noordam et al., Growth hormone (GH) secretion in children with Noonan syndrome: frequentlyabnormal without consequences for growth or response to GH treatment, CLIN ENDOCR, 54(1), 2001, pp. 53-59
Authors:
Boehmer, ALM
Bruggenwirth, H
Van Assendelft, C
Otten, BJ
Verleun-Mooijman, MCT
Niermeijer, MF
Brunner, HG
Rouwe, CW
Waelkens, JJ
Oostdijk, W
Kleijer, WJ
Van der Kwast, TH
De Vroede, MA
Drop, SLS
Citation: Alm. Boehmer et al., Genotype versus phenotype in families with androgen insensitivity syndrome, J CLIN END, 86(9), 2001, pp. 4151-4160
Authors:
van den Bergh, JPW
Noordam, C
Ozyilmaz, A
Hermus, ARMR
Smals, AGH
Otten, BJ
Citation: Jpw. Van Den Bergh et al., Calcaneal ultrasound imaging in healthy children and adolescents: Relationof the ultrasound parameters BUA and SOS to age, body weight, height, footdimensions and pubertal stage, OSTEOPOR IN, 11(11), 2000, pp. 967-976
Authors:
Kotzot, D
Balmer, D
Baumer, A
Chrzanowska, K
Hamel, BCJ
Ilyina, H
Krajewska-Walasek, M
Lurie, IW
Otten, BJ
Schoenle, E
Tariverdian, G
Schinzel, A
Citation: D. Kotzot et al., Maternal uniparental disomy 7 - review and further delineation of the phenotype, EUR J PED, 159(4), 2000, pp. 247-256
Authors:
Mul, D
Oostdijk, W
Otten, BJ
Rouwe, C
Jansen, M
Delemarre-van de Waal, HA
Waelkens, JJJ
Drop, SLS
Citation: D. Mul et al., Final height after gonadotrophin releasing hormone agonist treatment for central precocious puberty: The Dutch experience, J PED END M, 13, 2000, pp. 765-772
Authors:
Vietor, HE
Hamel, BCJ
van Bree, SPMJ
van der Meer, EMW
Smeets, DFCM
Otten, BJ
Holl, RA
Claas, FHJ
Citation: He. Vietor et al., Immunological tolerance in an HLA non-identical chimeric twin (vol 61, pg 190, 2000), HUMAN IMMUN, 61(7), 2000, pp. 720-720
Authors:
van der Kamp, HJ
Otten, BJ
Swinkels, LMJW
Sweep, CGJ
Monnens, LAH
Schroder, CH
Citation: Hj. Van Der Kamp et al., Influence of peritoneal loss of GHBP, IGF-I and IGFBP-3 on serum levels inchildren with ESRD, NEPH DIAL T, 14(1), 1999, pp. 257-258
Authors:
Kremer, H
Martens, JWM
van Reen, M
Verhoef-Post, M
Wit, JM
Otten, BJ
Drop, SLS
Delemarre-van de Waal, HA
Pombo-Arias, M
De Luca, F
Potau, N
Buckler, JMH
Jansen, M
Parks, JS
Latif, HA
Moll, GW
Epping, W
Saggese, G
Mariman, ECM
Themmen, APN
Brunner, HG
Citation: H. Kremer et al., A limited repertoire of mutations of the luteinizing hormone (LH) receptorgene in familial and sporadic patients with male LH-independent precociouspuberty, J CLIN END, 84(3), 1999, pp. 1136-1140
Authors:
Sas, TCJ
Keizer-Schrama, SMPFD
Stijnen, T
Jansen, M
Otten, BJ
Hoorweg-Nijman, JJG
Vulsma, T
Massa, GG
Rouwe, CW
Reeser, HM
Gerver, WJ
Gosen, JJ
Rongen-Westerlaken, C
Drop, SLS
Citation: Tcj. Sas et al., Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: Results of a randomized dose-response trial, J CLIN END, 84(12), 1999, pp. 4607-4612
Authors:
Boehmer, ALM
Brinkmann, AO
Sandkuijl, LA
Halley, DJJ
Niermeijer, MF
Andersson, S
de Jong, FH
Kayserili, H
de Vroede, MA
Otten, BJ
Rouwe, CW
Mendonca, BB
Rodrigues, C
Bode, HH
de Ruiter, PE
Delemarre-van de Waal, HA
Drop, SLS
Citation: Alm. Boehmer et al., 17 beta-hydroxysteroid dehydrogenase-3 deficiency: Diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations, J CLIN END, 84(12), 1999, pp. 4713-4721